BP has realized its first investment in China’s artificial intelligence (AI) sector by backing energy systems developer R&B Technology through a venture capital arm.
Ascendent Capital Partners has closed its third China fund with more than $1 billion in commitments, having increased the hard cap.
Longzhong Xinyi, a venture capital firm established by Hailong Xiang (pictured), formerly a senior executive at Baidu, has raised RMB200 million ($29 million) for its debut fund.
Zhiyun Health, a Chinese online healthcare services provider, has raised more than RMB1 billion ($144 million) across two rounds. It describes the investment as the largest private funding event globally in the chronic disease management space.
Transcenta Holding, a Chinese biotech company formed last year through the merger of MabSpace Bioscience and Hangzhou Just Biotherapeutics (HJB), has raised $100 million in an extended Series B funding round.
DataCloak, a Shenzhen-based data security start-up that employs the zero-trust approach, has raised $13 million in Series A funding led by Jeneration Capital.
General Atlantic has led a $69 million Series D round of funding for Adagene, a Chinese drug developer with one cancer treatment currently in phase one clinical trials in China and the US.
Chinese smart sensor maker Hesai Technology has raised a $173 million Series C round led by Germany’s Bosch Group and existing investor Lightspeed China Partners.
Tencent Holdings and XiangHe Capital have led a $73 million Series C round for China-based cybersecurity services provider NextData.
CF PharmTech, a Chinese devices maker focused on respiratory health, has raised $90 million in Series E funding led by local private equity investor New Alliance Capital.
Geneseeq, a Chinese genetic testing company that focuses on treatments for cancer, has raised RMB800 million ($115 million) in a funding round led by state-owned China Reform Holding Corporation.
Elpiscience, a Shanghai-based biopharmaceutical company has completed a $100 million Series B round of funding led by specialist healthcare GP Hyfinity Investments.
What industry participants had to say at AVCJ events on co-investment, technology opportunities in Vietnam, what LPs want to hear from GPs, Indian buyouts, long-dated funds, and late-stage deals in China deployment during times of uncertainty, responding...
Hua Capital, a Chinese investment firm that primarily focuses on the semiconductor industry, has agreed to acquire an Asia-based mobile LCD chip business from US-listed Synaptics for $120 million in cash.
The Carlyle Group has acquired a significant minority stake in Anxin Apartment, a Chinese serviced apartment operator that specializes in affordable housing for corporate clients.
Community group buying businesses are beginning to struggle in China despite considerable VC investment. Fresh produce retailer Benlai believes its online-to-offline hybrid model is more sustainable
Industry experts weigh in as a range of macro factors promise to reshape markets across the region. Political, demographic, and scientific variables loom large
Xreacloud, an industrial internet-of-things (IoT) platform incubated by Chinese state-owned construction machinery manufacturer XCMG, has raised RMB300 million ($43 million) in Series A funding.
China-headquartered Asian Infrastructure Investment Bank (AIIB) is set to anchor two private equity funds, including an energy-focused vehicle, with a total commitment of $125 million.
Shanghai Kechow Pharma, a Chinese small molecule targeted drug developer, has raised a $45 million Series C round led by Decheng Capital.
Baibu, a Chinese B2B trading and services platform for the textiles and fabrics industry, has raised a $300 million Series D round led by DST Global.
Ucommune, China’s largest co-working space player which is considered the local equivalent to troubled US operator WeWork, has filed for a US IPO.
Chinese drone manufacturer EHang traded flat on its NASDAQ debut following a $40 million IPO that priced at the bottom end of the indicative range.
WeLab, a Hong Kong financial technology start-up that abandoned plans for an IPO approximately 12 months ago, has raised $156 million in a new private funding round.